Pharmacy won’t be deregulated: Hooper

Mark Hooper
Sigma is entering a “growth phase where we have few business constraints” following the end of its contract with Chemist Warehouse Sigma has announced its financial results for the six months to 31 July 2019, saying its business transformation is on track to deliver $100 million or more in efficiency gains a year. It reported EBITDA

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘Factory medicine’ a risk with GP ownership
Next Push for the Pill